Skip to main content

Select Drug Profiles

Tafinlar and Mekinist: Two Oral Targeted Kinase Inhibitors for the Treatment of Patients with Metastatic Melanoma and BRAF Mutations

Lisa A. Raedler, PhD, RPh

New Directions in the Treatment of Multiple Myeloma: Reports on Carfilzomib Therapy from ASCO 2013 and EHA 2013

Lisa A. Raedler, PhD, RPh

Practice Management

FDA Expected to Approve Surrogate End Point for Neoadjuvant Breast Cancer Trials

Caroline Helwick

Lung Cancer, Oncology

Crizotinib Superior to Standard Chemotherapy in ALK-Positive Lung Cancer

Xofigo (Radium Ra 223 Dichloride): The First Alpha Particle–Emitting Radioactive Agent for the Treatment of Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases

Lisa A. Raedler, PhD, RPh

Cancer Care in 2013: Hope, Reality, and a Call to Action

Gary M. Owens, MD

Experts Debate Value of Bevacizumab in Newly Diagnosed Glioblastoma

Bevacizumab an Effective New Treatment Option for Relapsed Cervical Cancer

Sorafenib Effective in Metastatic Differentiated Thyroid Cancer

Prostate Cancer

New Analysis Confirms Radium Ra-223 Prolongs Survival in Patients with Metastatic CRPC, Regardless of Previous Docetaxel Therapy Status

Page 172 of 244
Results 1711 - 1720 of 2438